The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients
NCT02363764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2016-10-04
Summary
Accurate identification of lower respiratory tract pathogens is standard of care in the management of CF patients and it is therefore recommended to perform regular bacterial cultures, at least once a year, but some even recommend monthly cultures. This can be done through different methods, of which sputum and bronchoalveolar lavage (BAL) are the gold standard. However, BAL is an invasive method, not designated to repeat monthly. Therefore, the diagnosis of lower respiratory tract infections can be challenging in the non-expectorating CF patient. Other methods, such as induced sputum (IS), cough swabs and nasal swabs, have been developed to obtain bacterial cultures in these patients. Studies have investigated the reliability of these different sampling methods, however, with controversial conclusions.
Conditions
Interventions
- PROCEDURE
-
Nasal swab
Will be obtained by the physiotherapist in: * Expectorating CF patients * Non-expectorating CF patients * Bronchoscopy CF patients
- PROCEDURE
-
Cough swab
Will be obtained by the physiotherapist in: * Expectorating CF patients * Non-expectorating CF patients * Bronchoscopy CF patients
- PROCEDURE
-
Spontaneous expectorated sputum
Will be obtained by the physiotherapist in: \- Expectorating CF patients
- PROCEDURE
-
Induced sputum
Will be obtained by the physiotherapist in: * Non-expectorating CF patients * Bronchoscopy CF patients
- PROCEDURE
-
Bronchoalveolar lavage
Will be obtained by the pulmonologist in: \- Bronchoscopy CF patients
- OTHER
-
Questionnaire
Completing questionnaire on acceptability of different sampling methods by patients \>6 years of age
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Principal Investigators
-
Anne Malfroot, MD, PhD · Universitair Ziekenhuis Brussel - Cystic Fibrosis Clinic
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-10-31
More Related Trials
-
Characterization of Pulmonary Microbiome in Cystic Fibrosis Patients
NCT04735679 ·Status: UNKNOWN
-
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
NCT04341532 ·Status: COMPLETED
-
Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
NCT03736096 ·Status: COMPLETED
-
Cough-Generated Aerosols of NTM in Cystic Fibrosis
NCT01815866 ·Status: COMPLETED
-
Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis
NCT01693965 ·Status: COMPLETED ·Phase: NA
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF
NCT02464267 ·Status: COMPLETED
-
Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways
NCT04171583 ·Status: COMPLETED
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs
NCT00590330 ·Status: COMPLETED
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients
NCT02840136 ·Status: TERMINATED ·Phase: NA
-
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
NCT06188988 ·Status: ENROLLING_BY_INVITATION
-
Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients
NCT00677365 ·Status: COMPLETED ·Phase: PHASE2
-
Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
NCT02308267 ·Status: UNKNOWN
-
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
NCT00043225 ·Status: COMPLETED
-
Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
NCT00977158 ·Status: WITHDRAWN
-
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults
NCT02368080 ·Status: COMPLETED
-
18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients
NCT00684346 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome
NCT05088447 ·Status: TERMINATED
-
Evaluation of Nebulization and Positive Expiratory Pressure Combination
NCT02535130 ·Status: UNKNOWN ·Phase: NA
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients
NCT00669760 ·Status: COMPLETED
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA